Multi-year studies announced after Cass review found ‘insufficient evidence’ about effects on children with gender dysphoria
Two studies to investigate the impact of puberty blockers in young people with gender incongruence have been announced by researchers in the UK after an expert view said gender medicine was “built on shaky foundations”.
Puberty blockers were originally used to treat early onset puberty in children but have also been used off-label in children with gender dysphoria or incongruence.
